| 000 | 01770 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513222739.0 | ||
| 264 | 0 | _c20001121 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/01.hyp.36.4.642 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez-Lozada, L G | |
| 245 | 0 | 0 |
_aNifedipine prevents changes in nitric oxide synthase mRNA levels induced by cyclosporine. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cOct 2000 |
||
| 300 |
_a642-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aGlyceraldehyde-3-Phosphate Dehydrogenases _xmetabolism |
| 650 | 0 | 4 |
_aIsoenzymes _xgenetics |
| 650 | 0 | 4 |
_aKidney Cortex _xdrug effects |
| 650 | 0 | 4 |
_aKidney Medulla _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xdrug effects |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aGamba, G | |
| 700 | 1 | _aBolio, A | |
| 700 | 1 | _aJiménez, F | |
| 700 | 1 | _aHerrera-Acosta, J | |
| 700 | 1 | _aBobadilla, N A | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 36 _gno. 4 _gp. 642-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.36.4.642 _zAvailable from publisher's website |
| 999 |
_c10985267 _d10985267 |
||